TCRX logo

TScan Therapeutics (TCRX) Company Overview

Profile

Full Name:

TScan Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 16, 2021

Indexes:

Not included

Description:

TScan Therapeutics (TCRX) is a biotechnology company focused on developing innovative T cell receptor (TCR) therapies for cancer treatment. They aim to harness the body’s immune system to target and eliminate cancer cells, offering potential new options for patients with various types of tumors.

Key Details

Price

$2.08

Annual Revenue

$21.05 M(+55.52% YoY)

Annual EPS

-$1.36(+50.55% YoY)

Annual ROE

-71.29%

Beta

1.47

Events Calendar

Earnings

Next earnings date:

Mar 6, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 11, 24 Needham
Buy
Dec 11, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 12, 24 Needham
Buy
Nov 6, 24 Needham
Buy
Aug 13, 24 Wedbush
Outperform
Aug 13, 24 HC Wainwright & Co.
Buy
Aug 12, 24 Needham
Buy
Jun 4, 24 HC Wainwright & Co.
Buy
May 16, 24 BTIG
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for TScan Therapeutics?
  • Does TScan Therapeutics pay dividends?
  • What sector is TScan Therapeutics in?
  • What industry is TScan Therapeutics in?
  • What country is TScan Therapeutics based in?
  • When did TScan Therapeutics go public?
  • Is TScan Therapeutics in the S&P 500?
  • Is TScan Therapeutics in the NASDAQ 100?
  • Is TScan Therapeutics in the Dow Jones?
  • When was TScan Therapeutics's last earnings report?
  • When does TScan Therapeutics report earnings?
  • Should I buy TScan Therapeutics stock now?

What is the ticker symbol for TScan Therapeutics?

The ticker symbol for TScan Therapeutics is NASDAQ:TCRX

Does TScan Therapeutics pay dividends?

No, TScan Therapeutics does not pay dividends

What sector is TScan Therapeutics in?

TScan Therapeutics is in the Healthcare sector

What industry is TScan Therapeutics in?

TScan Therapeutics is in the Biotechnology industry

What country is TScan Therapeutics based in?

TScan Therapeutics is headquartered in United States

When did TScan Therapeutics go public?

TScan Therapeutics's initial public offering (IPO) was on July 16, 2021

Is TScan Therapeutics in the S&P 500?

No, TScan Therapeutics is not included in the S&P 500 index

Is TScan Therapeutics in the NASDAQ 100?

No, TScan Therapeutics is not included in the NASDAQ 100 index

Is TScan Therapeutics in the Dow Jones?

No, TScan Therapeutics is not included in the Dow Jones index

When was TScan Therapeutics's last earnings report?

TScan Therapeutics's most recent earnings report was on Nov 12, 2024

When does TScan Therapeutics report earnings?

The next expected earnings date for TScan Therapeutics is Mar 6, 2025

Should I buy TScan Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions